Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
Volume 0.21M
Average 0.38M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
No data available for this stock.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Pacira BioSciences, Inc. NASDAQ:PCRX | $1.46B | $36.46 | Undervalued | 176.9 | +49.94% |
Collegium Pharmaceutical, Inc. NASDAQ:COLL | $786.83M | $25.32 | Undervalued | 14.3 | -41.69% |
Scilex Holding Company NASDAQ:SCLX | $10.06M | $1.43 | Fairly Valued | -0.1 | -63.10% |
Continue the stock analysis
Jump to another research area for this company.